1st Quarter - Report — SAM ACTION, INC. for SAM ACTION, INC. (2021)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

SAM ACTION, INC.

Client

SAM ACTION, INC.

Income

—

Expenses

$10,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Apr 20, 2021	$10,000	Replaced
1st Quarter - Amendment	Apr 22, 2021	$10,000	Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Safety issues surrounding marijuana, marketing of high potency marijuana products to children.

Lobbyist	Covered position, as disclosed
LUKE ALBEE	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: Justice, Dept of (DOJ); Small Business Administration (SBA); White House Office; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; SENATE; Office of Natl Drug Control Policy (NDCP)

Government Issues GOV

Federal role in marijuana laws, the legalization of marijuana, criminal justice reform.

Lobbyist	Covered position, as disclosed
LUKE ALBEE	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Small Business Administration (SBA); SENATE; Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); White House Office; Justice, Dept of (DOJ)

Medical/Disease Research/Clinical Labs MED

H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marijuana Research Expansion Act, to lower the barriers of researching marijuana.

Lobbyist	Covered position, as disclosed
FREDERICK BAIRD New	—
JENNIFER BAIRD New	—

Contacted: Justice, Dept of (DOJ); SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office; Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); Small Business Administration (SBA)

Bills named: S. 2032 (117th), H.R. 3797 (117th)

Law Enforcement/Crime/Criminal Justice LAW

H.R.2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana, H.R.3884, MORE Act.

Lobbyist	Covered position, as disclosed
LUKE ALBEE	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: Drug Enforcement Administration (DEA); White House Office; SENATE; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA)

Bills named: H.R. 2093 (117th), H.R. 3884 (117th), S. 1028 (117th)

Alcohol and Drug Abuse ALC

The effects of marijuana on children, the nexus between marijuana and psychosis.

Lobbyist	Covered position, as disclosed
LUKE ALBEE New	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Food & Drug Administration (FDA); SENATE; Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); Small Business Administration (SBA)

Banking BAN

H.R.1595/S.1200 SAFE Banking Act on marijuana banking and investment.

Lobbyist	Covered position, as disclosed
LUKE ALBEE	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); White House Office; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Small Business Administration (SBA); Justice, Dept of (DOJ); SENATE

Bills named: H.R. 1595 (117th), S. 1200 (117th)

Health Issues HCR

The effects of marijuana on children, pregnant women and developing brains, the nexus between high potency marijuana and mental illness.

Lobbyist	Covered position, as disclosed
LUKE ALBEE	Chief of Staff, Senator Leahy; Chief of Staff, Mark Warner; Staff, Governor Dukakis
FREDERICK BAIRD	—
JENNIFER BAIRD	—

Contacted: Food & Drug Administration (FDA); Small Business Administration (SBA); White House Office; Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); SENATE; Justice, Dept of (DOJ)

Small Business SMB

Preventing federally illegal enterprises from gaining a special carve out to access federally subsidized loans or grants.

Lobbyist	Covered position, as disclosed
FREDERICK BAIRD New	—
JENNIFER BAIRD New	—

Contacted: Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); White House Office; Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.